Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) Return on Sales (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Return on Sales data on record, last reported at 0.35% in Q3 2025.

  • For Q3 2025, Return on Sales rose 148.0% year-over-year to 0.35%; the TTM value through Sep 2025 reached 15.66%, up 2842.0%, while the annual FY2024 figure was 80.56%, 5108.0% down from the prior year.
  • Return on Sales reached 0.35% in Q3 2025 per FBIO's latest filing, up from 2.18% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.73% in Q4 2023 and bottomed at 88.0% in Q2 2022.
  • Average Return on Sales over 5 years is 6.59%, with a median of 2.36% recorded in 2021.
  • Peak YoY movement for Return on Sales: crashed -8561bps in 2022, then skyrocketed 8515bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 3.41% in 2021, then decreased by -3bps to 3.5% in 2022, then surged by 121bps to 0.73% in 2023, then decreased by -21bps to 0.57% in 2024, then tumbled by -160bps to 0.35% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 0.35% in Q3 2025, 2.18% in Q2 2025, and 1.66% in Q1 2025.